宜華健康(000150.SZ):終止2020年非公開發行A股事項
格隆匯 1 月 11日丨宜華健康(000150.SZ)公佈,公司於2020年3月17日召開第七屆董事會第四十三次會議,審議通過《關於公司2020年度非公開發行A股股票方案的議案》、《關於公司與認購對象簽訂<非公開發行A股股票之附條件生效的股份認購合同>的議案》等相關議案。此次非公開事項尚未經公司股東大會、中國證券監督管理委員會核准。
公司擬向中冠寶投資有限責任公司、華夏人壽股份有限公司非公開發行A股股票,並均與各方簽署《非公開發行A 股股票之附條件生效的股份認購合同》。
公司積極推進此次非公開發行A股股票的發行工作,但鑑於目前相關監管政策、資本市場環境及公司發行方案發生變化,公司綜合考慮實際情況、發展規劃等諸多因素,並與相關各方充分的溝通及審慎論證,決定終止前次非公開發行股票事項。公司在修改和調整方案並履行董事會、股東大會審議程序後,並將儘快向中國證券監督管理委員會遞交非公開發行的申請資料。
公司於2021年1月11日召開第八屆董事會第七次會議、第八屆監事會第三次會議,審議通過《關於終止公司2020年度非公開發行A股股票事項的議案》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.